SCHEMBL29462512

SCHEMBL29462512

CCO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(c3nccnn3)C2)s1)c1ccc(F)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GLS O94925 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19097779 1.00 GLS (1.00) GLS
SCHEMBL29462523 1.00 GLS (1.00) GLS
SCHEMBL23721767 1.00 GLS (1.00) GLS
SCHEMBL17296031 1.00 GLS (1.00) GLS
SCHEMBL17309272 0.92 GLS (1.00) GLS
SCHEMBL20373653 0.92 GLS (1.00) GLS
SCHEMBL17309291 0.92 GLS (1.00) GLS
SCHEMBL19097774 0.91 GLS (1.00) GLS
SCHEMBL19097733 0.91 GLS (1.00) GLS
SCHEMBL19097764 0.91 GLS (1.00) GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3383873-B1 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER CANCER RESEARCH TECH LTD (GB) 2022-03-09 — — EP disclosed
Send feedback